$0.1146
-0.0054-4.5%
At close: Nov 20, 4:00 PM EST

AIM ImmunoTech (AIM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.21 | $-0.09 | -133.3 % |
| Q2 | Aug 10, 2026 | $-0.43 | $-0.12 | -258.3 % |
| Q4 | Mar 27, 2026 | $-1.44 | $-1.08 | -33.3 % |
| Q3 | Nov 18, 2025 | $-1.57 | $-0.98 | -60.2 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2025 | $25.00K | $100.00K | -75.0 % |
| Q1 | May 15, 2025 | $16.00K | $100.00K | -84.0 % |
| Q4 | Mar 27, 2025 | $45.00K | $45.00K | 0.00 % |
| Q3 | Nov 15, 2024 | $35.00K | $11.67K | 199.9 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.12 | — | $-1.08 |
| Actual | $-0.21 | $-0.43 | $-0.69 | $-1.44 |
| Surprise | -133.3% | -258.3% | — | -33.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $22000 | $26000 | $22000 | $21000 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.09 | $-0.10 |
| Revenue | ||
| Consensus | — | — |